Generex Biotechnology Corporation
GNBTQ
OTC PK
| 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | 04/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 302.06% | 121.48% | 54.28% | -94.81% | -70.41% |
| Total Receivables | -63.17% | -29.35% | 18.95% | 354.27% | -92.13% |
| Inventory | -74.52% | -28.24% | -1.20% | 104.49% | 264.40% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -18.34% | -22.79% | -32.02% | 20.53% | 185.10% |
| Total Current Assets | 17.93% | -5.42% | 9.05% | 28.90% | -43.11% |
|
|
|||||
| Total Current Assets | 17.93% | -5.42% | 9.05% | 28.90% | -43.11% |
| Net Property, Plant & Equipment | -28.76% | -50.08% | -68.62% | -49.64% | -31.06% |
| Long-term Investments | -11.34% | -11.34% | -11.34% | -9.94% | 10.83% |
| Goodwill | -11.34% | -11.34% | -11.34% | -9.94% | 10.83% |
| Total Other Intangibles | -17.36% | -16.39% | -15.44% | -4.77% | -20.77% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.07% | -32.28% | -36.69% | -30.07% | -98.46% |
| Total Assets | -11.51% | -12.65% | -12.16% | -8.57% | -3.96% |
|
|
|||||
| Total Accounts Payable | 90.19% | 63.02% | 49.08% | 62.81% | 8.43% |
| Total Accrued Expenses | 26.55% | -- | -- | 27.99% | -- |
| Short-term Debt | -1.11% | -88.64% | -86.86% | -86.13% | -80.89% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.98% | 11,021.76% | 13,049.67% | -- | -- |
| Total Finance Division Other Current Liabilities | 466.01% | 199.72% | 133.15% | 0.00% | -22.36% |
| Total Other Current Liabilities | 466.01% | 199.72% | 133.15% | 0.00% | -22.36% |
| Total Current Liabilities | 61.34% | 58.92% | 53.06% | 42.93% | 37.70% |
|
|
|||||
| Total Current Liabilities | 61.34% | 58.92% | 53.06% | 42.93% | 37.70% |
| Long-Term Debt | 10.43% | -- | -- | -- | -- |
| Short-term Debt | -1.11% | -88.64% | -86.86% | -86.13% | -80.89% |
| Capital Leases | 69.98% | 57.63% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 140.58% | 285.86% | 177.11% | 27.42% | -7.78% |
| Total Liabilities | 77.25% | 109.28% | 79.96% | 40.59% | 26.22% |
|
|
|||||
| Common Stock & APIC | -1.24% | -0.03% | 0.33% | 5.19% | 6.68% |
| Retained Earnings | -8.88% | -12.41% | -8.60% | -7.96% | -6.39% |
| Treasury Stock & Other | 2,976.73% | 6,442.67% | -2.36% | -2.12% | -96.97% |
| Total Common Equity | -344.89% | -370.29% | -356.61% | -130.67% | -3.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -344.89% | -370.29% | -356.61% | -130.67% | -3.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -11.08% | -29.81% | -29.46% | -35.52% | -47.08% |
| Total Equity | -4,053.68% | -1,469.80% | -458.18% | -167.12% | -91.92% |
|
|
|||||
